NCT06684782

Brief Summary

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by pathologic intraneuronal alpha-synuclein-positive Lewy bodies and neuronal cell loss. The cardinal clinical symptoms and signs of PD are bradykinesia, rigidity, tremor, postural instability, and freezing attacks. The prevalence of PD increases with age, affecting 1-2% of the population over the age of 65 years, and 3% of those over 85 years. Restless legs syndrome (RLS) represents disturbing symptoms in lower limbs that lead to the urge to move, occurring in rest periods. Movements can partially or completely relieve these abnormal feelings. In 2014, the International RLS Study Group (IRLSSG) established five mandatory criteria for the diagnosis of RLS. Several studies supported that RLS and PD may share pathophysiological mechanisms.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
310

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Dec 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Dec 2024Nov 2026

First Submitted

Initial submission to the registry

November 10, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 12, 2024

Completed
19 days until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

May 15, 2025

Status Verified

May 1, 2025

Enrollment Period

1.9 years

First QC Date

November 10, 2024

Last Update Submit

May 12, 2025

Conditions

Keywords

restless leg syndromeparkinson's diseaseprevalenceThai population

Outcome Measures

Primary Outcomes (1)

  • The prevalence of restless leg syndrome in patients with Parkinson's disease

    At the time of recruitment

Secondary Outcomes (1)

  • Clinical characteristics of Parkinson's disease patients with restless leg syndrome

    At the time of recruitment

Study Arms (1)

Patients with parkinson's disease

Other: Screening for symptoms of restless leg syndrome

Interventions

The patients will be screened for restless leg syndrome by clinical questioning.

Patients with parkinson's disease

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Parkinson's disease aged from 18 to 80 years who met the UK Parkinson's Disease Society Brain Bank Diagnostic Criteria. The patients must regularly visit the movement disorders clinic at least 2 times per year.

You may qualify if:

  • Patients with Parkinson's disease aged from 18 to 80 years who met the United Kingdom Parkinson's Disease Society (UKPDS) Brain Bank Diagnostic criteria.

You may not qualify if:

  • Patients with atypical or secondary parkinsonism.
  • Patients with Mini-mental status exam (MMSE) less than 24 of 30.
  • Patients with secondary causes of restless leg syndrome including end-stage renal disease, iron deficiency anemia and pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Siriraj Hospital, Mahidol University

Bangkok, Bangkok, 10700, Thailand

RECRUITING

Siriraj Hospital, Mahidol University

Bangkok, Thailand, 10310, Thailand

RECRUITING

MeSH Terms

Conditions

Restless Legs SyndromeParkinson Disease

Interventions

Mass Screening

Condition Hierarchy (Ancestors)

Nervous System DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersParasomniasMental DisordersParkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesDiagnostic ServicesPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health Practice

Study Officials

  • Jindapa Srikajon, Doctor of Medicine

    Siriraj Sleep Center, Faculty of Medicine, Siriraj Hospital, Mahidol University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jindapa Srikajon, Doctor of Medicine

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD.

Study Record Dates

First Submitted

November 10, 2024

First Posted

November 12, 2024

Study Start

December 1, 2024

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

May 15, 2025

Record last verified: 2025-05

Locations